On November 3, 2023, Mustang Bio, Inc. closed the transaction. The transaction included participation from a single investor. In connection with the offering, the placement agent received is $308,000.08 and warrants to purchase up to 155,294 shares of common stock exercisable at $2.125 per share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3178 USD | +8.46% | +0.54% | -76.46% |
May. 02 | Mustang Bio, Inc. announced that it has received $3.3 million in funding | CI |
Apr. 30 | Mustang Bio Prices Public Offering of 16.9 Million Shares, Accompanying Warrants | MT |
1st Jan change | Capi. | |
---|---|---|
-76.46% | 3.69M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- MBIO Stock
- News Mustang Bio, Inc.
- Mustang Bio, Inc. announced that it has received $4.742942 million in funding